Women without COVID-19 | ||||||
Annual births | Level of commitment to BFHI | |||||
< 1500 | ≥ 1500 | Phase < 2D | Phase ≥ 2D | |||
N = 25 n (%) | N = 25 n (%) | p-value | N = 19 n (%) | N = 31 n (%) | p-value | |
Companion of choice during labour | 25 (100) | 25 (100) | 1 | 19 (100) | 31 (100) | 1 |
Companion of choice during delivery | 6 (24) | 6 (24) | 1 | 2 (10.5) | 10 (32.3) | 0.08 |
Immediate skin-to-skin contact after birth | 16 (64) | 10 (40) | 0.004 | 7 (36.8) | 19 (61.3) | 0.09 |
Breastfeeding in the first hour of life | 16 (64) | 9 (36) | 0.04 | 9 (47.4) | 16 (51.6) | 0.77 |
Rooming-in | 25 (100) | 24 (96) | 0.31 | 19 (100) | 30 (96.8) | 0.43 |
Companion of choice during hospital stay | 23 (92) | 22 (88) | 0.64 | 17 (89.5) | 28 (90.3) | 0.92 |
Breastfeeding support | 22 (88) | 25 (100) | 0.07 | 16 (84.2) | 31 (100) | 0.02 |
Follow-up if discharged early | 24 (96) | 21 (84) | 0.16 | 16 (84.2) | 29 (93.5) | 0.28 |
Special breastfeeding support measures | 11 (44) | 7 (28) | 0.24 | 6 (31.6) | 12 (38.7) | 0.61 |
Women with mild COVID-19 | ||||||
Annual births | Level of commitment to BFHI | |||||
< 1500 | ≥ 1500 | Phase < 2D | Phase ≥ 2D | |||
N = 25 n (%) | N = 25 n (%) | p-value | N = 19 n (%) | N = 31 n (%) | p-value | |
Companion of choice during labour | 21 (84) | 21 (84) | 1 | 15 (78.9) | 27 (87.1) | 0.44 |
Companion of choice during delivery | 5 (20) | 4 (16) | 0.71 | 2 (10.5) | 7 (22.6) | 0.28 |
Immediate skin-to-skin contact after birth | 11 (44) | 5 (20) | 0.07 | 2 (10.5) | 14 (45.2) | 0.01 |
Breastfeeding in the first hour of life | 13 (52) | 5 (20) | 0.02 | 5 (26.3) | 13 (41.9) | 0.26 |
Rooming-in | 18 (72) | 19 (76) | 0.75 | 11 (57.9) | 26 (83.9) | 0.04 |
Companion of choice during hospital stay | 17 (68) | 17 (68) | 1 | 10 (52.6) | 24 (77.4) | 0.07 |
Breastfeeding support | 20 (80) | 19 (76) | 0.73 | 12 (63.2) | 27 (87.1) | 0.047 |
Follow-up if discharged early | 23 (92) | 16 (64) | 0.016 | 15 (78.9) | 24 (77.4) | 0.90 |
Special breastfeeding support measures | 11 (44) | 9 (36) | 0.56 | 5 (26.3) | 15 (48.4) | 0.12 |
Women with severe COVID-19 | ||||||
Annual births | Level of commitment to BFHI | |||||
< 1500 | ≥ 1500 | Phase < 2D | Phase ≥ 2D | |||
N = 22 n (%) | N = 25 n (%) | p-value | N = 18 n (%) | N = 29 n (%) | p-value | |
Companion of choice during labour | 15 (68.2) | 17 (68) | 0.99 | 11 (61.1) | 21 (72.4) | 0.42 |
Companion of choice during delivery | 2 (9.1) | 4 (16) | 0.48 | 1 (5.5) | 5 (17.2) | 0.24 |
Milk expression encouraged and supported | 17 (77.3) | 20 (80) | 0.82 | 11 (61.1) | 26 (89.7) | 0.02 |